Sex difference in Parkinson’s disease hospitalization rates in Brazil (2010–2024) Authors: Rebeca Oliveira da Silva, Luís Gabriel de Sousa Fontenele, Othon Trevisan Meira, João Pedro Araújo Nunes, Henrique Cian da Cruz, Olivier Uwishema, Henrique Cal Published: 2026 ABSTRACT Background and aimSex-related differences in the epidemiology and outcomes of Parkinson’s disease (PD) have been consistently reported. However, population-level evidence on disparities in hospitalization burden remains limited, particularly in low- and middle-income countries. This study aimed to assess sex-specific differences in hospitalization rates for PD in Brazil over a 15-year period.Methods/designNationwide hospital admission data for Parkinson’s disease were obtained from the Brazilian national hospital information system for the period 2010–2024. Resident population estimates were used to calculate hospitalization rates per 1,000,000 inhabitants for males and females. Descriptive analyses included mean rates and graphical distribution assessment. Both crude and age-standardized rates were calculated. Sex-specific differences were assessed using Wilcoxon signed-rank tests. Effect size was estimated using mean rate ratios (RR) with 95% confidence intervals. Durbin–Watson test was applied and Newey–West standard errors were used to obtain robust estimates. All analyses were conducted using Python 3.10.12.ResultsA total of 17,108 hospitalizations for Parkinson’s disease were analyzed, with an overall mean crude hospitalization rate of 5.58 per 1,000,000 inhabitants. Males consistently exhibited higher crude hospitalization rates than females (6.67 vs. 4.53 per 1,000,000 inhabitants). This difference was statistically significant (p < 0.001) and associated with a very large effect size (RR = 1.496; 95% CI: 1.387–1.605). The findings remained robust after correction for serial autocorrelation.ConclusionsHospitalization rates for Parkinson’s disease are significantly higher among males than females in Brazil. The observed disparity was substantial and statistically robust across multiple analytical approaches. These findings highlight the importance of sex-sensitive healthcare strategies and targeted interventions to reduce preventable hospitalizations and optimize Parkinson’s disease management.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12883-026-05102-1. Introduction Parkinson’s disease (PD) is a common and progressive neurodegenerative disorder that predominantly affects older adults and represents a major cause of disability worldwide [1, 2]. Beyond its cardinal motor manifestations, PD is characterized by a broad spectrum of non-motor symptoms that substantially compromise functional independence and quality of life [2–5]. The etiology of PD is multifactorial, involving both genetic and environmental factors [5]. Pathologically, the disease is characterized by degeneration of dopaminergic neurons in the substantia nigra, leading to reduced dopamine levels in the basal ganglia and, consequently, impaired motor control [2, 6]. PD is the second most prevalent neurodegenerative disorder worldwide [7], second only to Alzheimer’s disease [8]. Its incidence and prevalence increase with age and are higher among men [1, 7, 9]. Men not only have a higher risk of developing PD but also differ from women in clinical phenotype, disease progression, and therapeutic response [5, 10]. Hormonal, genetic, and behavioral factors have been proposed as potential explanations for these sex-related disparities [7, 11, 12]. These differences are also reflected in hospitalization patterns associated with PD. Epidemiological studies have shown that men with PD tend to experience higher hospitalization and mortality rates, possibly due to greater clinical severity, comorbidities, and risk-related lifestyle factors. Conversely, women often experience longer hospital stays and greater functional impairment, particularly in advanced stages of the disease [13–17]. Hospital admissions in PD usually indicate acute complications such as falls, infections, medication-related adverse effects, or decompensation of motor and non-motor symptoms, and therefore represent a meaningful proxy of disease burden and healthcare system strain. Analyzing sex-specific differences in hospitalization rates is essential for understanding inequalities in clinical management and for optimizing care strategies and public health policies targeting the PD population [14, 16]. Methods Study design This ecological time-series and analytical study analyzed data from 2010 to 2024 to assess sex-specific differences in hospitalization rates for Parkinson’s disease (PD), comparing trends and overall burden between males and females over a 15-year period. Study area description Brazil is subdivided into five geographic regions (North, Northeast, Midwest, Southeast, and South), 26 states and a Federal District, and 5,570 municipalities. Despite being one of the world’s largest economies, Brazil faces significant social inequality, with an HDI of 0.710 and a Gini index of 0.481. Data source and definitions Hospitalization data were obtained from the Hospital Information System of the Brazilian Unified Health System (SIH/SUS), a public nationwide administrative database maintained by DATASUS (Ministry of Health) that records all hospital admissions financed by the public health system. Data were retrieved through TABNET (http://datasus.saude.gov.br/informacoes-de-saude-tabnet/), the open-access online tabulation platform provided by DATASUS. We specifically utilized the ICD-10 code G20 restricted exclusively to the primary diagnosis field to identify Parkinson’s disease cases. It is important to note that the SIH/SUS registers hospital admission events (Authorizations for Hospital Admission - AIH) rather than individual patients; therefore, repeated admissions of the same individual are counted as separate events. Annual resident population estimates, stratified by sex and 5-year age groups, were obtained directly from the Brazilian Institute of Geography and Statistics (IBGE) and used as denominators. To control for the aging of the Brazilian population over the 15-year period, we calculated Age-Standardized Rates (ASR) by the direct method, utilizing the WHO World Standard Population as the reference [Ahmad et al., 2001; Supplementary Table S2]. The total resident population of Brazil was used as a denominator, consistent with established practice for national administrative database analyses. Crude hospitalization rates were calculated as the number of G20-coded admissions (numerator) divided by the corresponding IBGE resident population estimates (denominator), and expressed per 1,000,000 inhabitants. Statistical analysis Descriptive statistics and graphical distribution analysis were used to summarize both crude and age-standardized hospitalization rates. To analyze temporal trends in hospitalization rates over the 15-year study period (2010–2024), we employed advanced statistical modeling frameworks to appropriately account for the underlying data structure: Poisson Regression: Given that the rates are derived from count data with population denominators, we utilized a Poisson regression model using absolute counts of hospitalizations as the dependent variable and the log(population) as the offset. We reported the Incidence Rate Ratio (IRR), 95% confidence intervals (CIs), and p-values.Time-Series Trend Analysis (GLS): Initial diagnostic tests revealed extremely strong positive serial autocorrelation in the time-series data (Durbin-Watson = 0.066). To mitigate this and evaluate the absolute direction and magnitude of the temporal trend, we employed Generalized Least Squares (GLS) regression explicitly modeling an AR(1) error structure (Prais-Winsten regression). This allowed for robust extraction of the β1 trend coefficient, 95% CIs, and p-values. As a secondary validation for robust standard errors, a Newey-West HAC-corrected model with lag = 1 was also evaluated. Additionally, the overall crude percent change was calculated to quantify the absolute variation between 2010 and 2024. Poisson Regression: Given that the rates are derived from count data with population denominators, we utilized a Poisson regression model using absolute counts of hospitalizations as the dependent variable and the log(population) as the offset. We reported the Incidence Rate Ratio (IRR), 95% confidence intervals (CIs), and p-values. Poisson Regression: Given that the rates are derived from count data with population denominators, we utilized a Poisson regression model using absolute counts of hospitalizations as the dependent variable and the log(population) as the offset. We reported the Incidence Rate Ratio (IRR), 95% confidence intervals (CIs), and p-values. Time-Series Trend Analysis (GLS): Initial diagnostic tests revealed extremely strong positive serial autocorrelation in the time-series data (Durbin-Watson = 0.066). To mitigate this and evaluate the absolute direction and magnitude of the temporal trend, we employed Generalized Least Squares (GLS) regression explicitly modeling an AR(1) error structure (Prais-Winsten regression). This allowed for robust extraction of the β1 trend coefficient, 95% CIs, and p-values. As a secondary validation for robust standard errors, a Newey-West HAC-corrected model with lag = 1 was also evaluated. Additionally, the overall crude percent change was calculated to quantify the absolute variation between 2010 and 2024. Time-Series Trend Analysis (GLS): Initial diagnostic tests revealed extremely strong positive serial autocorrelation in the time-series data (Durbin-Watson = 0.066). To mitigate this and evaluate the absolute direction and magnitude of the temporal trend, we employed Generalized Least Squares (GLS) regression explicitly modeling an AR(1) error structure (Prais-Winsten regression). This allowed for robust extraction of the β1 trend coefficient, 95% CIs, and p-values. As a secondary validation for robust standard errors, a Newey-West HAC-corrected model with lag = 1 was also evaluated. Additionally, the overall crude percent change was calculated to quantify the absolute variation between 2010 and 2024. Sex disparities in hospitalization were operationally defined as the differential magnitude of crude hospitalization rates between males and females, quantified using the Mean Rate Ratio (MRR), calculated as the ratio of the mean annual male to mean annual female hospitalization rate across the 15-year study period. Values > 1.0 indicate male predominance. The MRR was computed with its 95% Confidence Interval across the 15-year series. A Wilcoxon signed-rank test was employed to assess sex differences in annual hospitalization rates across the 15-year series (n = 15 paired observations). All analyses were performed using Python version 3.10.12 with the scipy, seaborn, and statsmodels libraries. All statistical tests were two-tailed, and statistical significance was set at p < 0.05. Results A total of 17,108 hospital admission events attributable to Parkinson’s disease as a primary diagnosis were recorded in Brazil during the study period. As shown in Fig. 1 Age-Standardized hospitalization rates stratified by sex followed distinct temporal trajectories, with higher values consistently observed among males across the 15-year period. Fig. 1Age-Standardized temporal evolution of hospitalization rates related to Parkinson’s disease in Brazil by sex, 2010–2024 Age-Standardized temporal evolution of hospitalization rates related to Parkinson’s disease in Brazil by sex, 2010–2024 Trend analysis by sex and age At the national level, overall crude hospitalization rates increased from 5.27 to 6.65 per 1,000,000 inhabitants between 2010 and 2024, representing an overall increase of 26.04%. However, this global trend was not statistically significant when adjusted for temporal autocorrelation via GLS AR(1) modeling (p = 0.686) or Poisson regression (p = 0.279). Marked sex-based heterogeneity was observed in both crude (Table 1) and age-standardized analyses (Table 2). Among males, crude hospitalization rates increased from 5.99 to 8.55 per 1,000,000 inhabitants (42.74% crude increase), demonstrating a statistically significant risk increase over time in the Poisson model (IRR = 1.0079; 95% CI: 1.0033 to 1.0125; p < 0.001). Following age standardization (ASR), the male rate was 7.13 per 1,000,000 in 2010 and 7.39 in 2024 (+ 3.65%), with the Poisson model remaining statistically significant. Table 1Crude and age-standardized hospitalization rates for Parkinson’s disease in Brazil (2010–2024), stratified by sex and total populationGroupCrude Rate 2010Crude Rate 2024Crude Change (%)ASR 2010ASR 2024ASR Change (%)Female4.584.845.684.553.44-24.4Male5.998.5542.747.137.393.65Total5.276.6526.195.725.24-8.39IRR Incidence Rate Ratio, LR Linear Regression with AR(1) error structure (GLS) Table 1Crude and age-standardized hospitalization rates for Parkinson’s disease in Brazil (2010–2024), stratified by sex and total populationGroupCrude Rate 2010Crude Rate 2024Crude Change (%)ASR 2010ASR 2024ASR Change (%)Female4.584.845.684.553.44-24.4Male5.998.5542.747.137.393.65Total5.276.6526.195.725.24-8.39IRR Incidence Rate Ratio, LR Linear Regression with AR(1) error structure (GLS) Crude and age-standardized hospitalization rates for Parkinson’s disease in Brazil (2010–2024), stratified by sex and total population IRR Incidence Rate Ratio, LR Linear Regression with AR(1) error structure (GLS) Table 2Age-Adjusted trend analysis of hospitalization rates for Parkinson’s disease in Brazil (2010–2024), stratified by sexGroupGLS B1 (Crude)B1 CI (Crude)GLS p (Crude)GLS B1 (ASR)B1 CI (ASR)GLS p (ASR)Poisson IRRIRR CI 95%Poisson pFemale-0.0267-0.1904 to 0.1370.73047-0.1171-0.2546 to 0.02050.088850.98450.9792 to 0.98990Male0.0837-0.0769 to 0.24430.2807-0.0767-0.2256 to 0.07210.285511.00791.0033 to 1.01250.00072Total0.0306-0.1271 to 0.18830.68173-0.0963-0.2368 to 0.04430.162690.99810.9946 to 1.00160.27912(ASR calculated via direct standardization using the WHO World Standard Population. IRR Incidence Rate Ratio, LR Linear Regression with AR(1) error structure (GLS) Table 2Age-Adjusted trend analysis of hospitalization rates for Parkinson’s disease in Brazil (2010–2024), stratified by sexGroupGLS B1 (Crude)B1 CI (Crude)GLS p (Crude)GLS B1 (ASR)B1 CI (ASR)GLS p (ASR)Poisson IRRIRR CI 95%Poisson pFemale-0.0267-0.1904 to 0.1370.73047-0.1171-0.2546 to 0.02050.088850.98450.9792 to 0.98990Male0.0837-0.0769 to 0.24430.2807-0.0767-0.2256 to 0.07210.285511.00791.0033 to 1.01250.00072Total0.0306-0.1271 to 0.18830.68173-0.0963-0.2368 to 0.04430.162690.99810.9946 to 1.00160.27912(ASR calculated via direct standardization using the WHO World Standard Population. IRR Incidence Rate Ratio, LR Linear Regression with AR(1) error structure (GLS) Age-Adjusted trend analysis of hospitalization rates for Parkinson’s disease in Brazil (2010–2024), stratified by sex (ASR calculated via direct standardization using the WHO World Standard Population. IRR Incidence Rate Ratio, LR Linear Regression with AR(1) error structure (GLS) In contrast, females showed a different trajectory. While crude rates slightly increased from 4.58 to 4.84 (5.56%), the age-standardized rates actually demonstrated a decline from 4.55 to 3.44 per 1,000,000 inhabitants (− 24.4%), indicating that the crude increase was largely driven by demographic aging. The Poisson regression for females confirmed a statistically significant temporal reduction in admission risk (IRR = 0.9845; 95% CI: 0.9792 to 0.9899; p < 0.001). Age-stratified analyses revealed that the highest absolute rates and most pronounced temporal dynamics occurred in the older age brackets (Table S3). Detailed crude rates for every 5-year age stratum by year are available in Supplementary Table S1. The temporal trends segregated by age strata are visually summarized in Fig. 2. Fig. 2Temporal trends in age-specific hospitalization rates for Parkinson’s disease in Brazil (2010–2024) Temporal trends in age-specific hospitalization rates for Parkinson’s disease in Brazil (2010–2024) Group comparison analysis Across the entire 15-year study period, males exhibited significantly higher hospitalization rates than females. The analysis yielded a Mean Rate Ratio (M/F) of 1.496 (95% CI: 1.387–1.605), indicating an approximately 50% higher average risk of hospitalization for men compared to women. A Wilcoxon signed-rank test confirmed a highly significant sex difference (W = 0.000, p < 0.001, n = 15). Applying the Newey-West HAC-correction further supported these differences (Male trend: β₁=0.0521, p = 0.388; Female trend: β₁=−0.0699, p = 0.163). As illustrated in Fig. 3, boxplots demonstrate consistently higher median values and greater absolute dispersion among males across all affected age groups. Fig. 3Distribution of annual Parkinson’s disease hospitalizations by age group and sex in Brazil (2010–2024) Distribution of annual Parkinson’s disease hospitalizations by age group and sex in Brazil (2010–2024) Discussion This nationwide time-series analysis provides the first comprehensive long-term assessment of sex-related disparities in Parkinson’s disease (PD) hospitalizations in Brazil between 2010 and 2024. The principal finding was that males consistently exhibited higher hospitalization rates than females throughout the study period, with a mean rate ratio (MRR) of 1.496. This difference remained robust across multiple analytical approaches, including rate ratio estimation and Poisson-based modeling, supporting the consistency of the observed disparity at the population level. Although national hospitalization rates increased from 5.27 to 6.65 per 1,000,000 inhabitants during the study period, trend analyses accounting for temporal autocorrelation did not demonstrate a statistically significant overall temporal trend. However, this apparent stability concealed marked sex-based heterogeneity. These contrasting patterns suggest that the burden of acute PD-related complications has expanded more rapidly in men, even in the absence of statistically significant temporal trends [18]. The observed sex disparity aligns with the established global pattern of male predominance in PD incidence, prevalence, and disability burden [19, 20]. Global Burden of Disease data consistently show higher incidence, prevalence, and disability-adjusted life years (DALYs) among men [21]. Similar findings regarding the predominance of males among hospitalized PD patients have been reported in European cohorts. A nationwide study in Spain (2010–2019), for example, documented an increasing trend in PD hospitalizations accompanied by a growing proportion of male patients. These observations indicate that the male-specific burden of PD hospitalization reflects mechanisms that are not unique to the Brazilian context [22]. However, the temporal pattern observed in Brazil presents a notable regional contrast. While the Brazilian data indicated a substantial, though not statistically significant, increase in the national rate of PD hospitalizations (26.04% change, 2010–2024), the trend in other high-income countries appears more stable or less steep. A long-term study in Denmark (1995–2019) reported that the rate of first-time hospitalization for PD remained relatively stable throughout the 25-year period for both men and women [23]. This stability in Denmark, coupled with the marked increase in Brazil, particularly the 42.59% change in male hospitalization rates, suggests that the Brazilian health system may be experiencing a more rapid growth in the acute care burden of PD, may be associated with a regional particularities such as improved diagnosis, changes in population aging dynamics, or differences in access to outpatient care [24]. The persistence and magnitude of the observed sex disparity suggest that hospitalization dynamics in PD are shaped by interacting biological, clinical, and systemic factors. Clinically, males tend to experience earlier disease onset and greater motor severity, which contribute to faster accumulation of disability [25]. Male patients also present higher rates of complications related to immobility, such as falls, respiratory infections, and urinary dysfunctions, which are frequent triggers for hospitalization. This vulnerability is compounded by a higher prevalence of cardiovascular and metabolic comorbidities, which are commonly reported among hospitalized PD patients [26]. Biological influences, including the potential neuroprotective and anti-dopaminergic effects of estrogens, may also contribute to sex-related differences in disease course [27]. Estrogens are hypothesized to exert neuroprotective roles through antioxidant activity and modulation of growth factors, which could slow the progression of dopaminergic neuron loss in females [28]. However, these mechanisms alone cannot account for the robust and systemic disparities in hospitalization observed here. Taken together, these findings indicate that the observed sex gap in hospitalization likely reflects not only biological vulnerability but also differences in comorbid burden, healthcare utilization, and systemic access, warranting further exploration in future analyses [25–28]. The longitudinal pattern of PD hospitalizations in Brazil must also be interpreted in light of demographic transformations. The absolute growth in hospitalization rates, particularly the 42.59% increase among males, likely reflects the accelerated aging of the Brazilian population. Because PD prevalence rises sharply with age, demographic transition remains a major driver of disease burden and healthcare utilization [29]. The temporal variability observed in hospitalization rates should also be influenced by changes in the diagnostic and management capacity of the disease. Expanding the care network and increasing awareness of PD may lead to a higher diagnosis rate and, consequently, more reported health events, including hospitalizations. However, it is crucial to consider the impact of external events, such as the COVID-19 pandemic [30]. Previous studies, such as that by Vasconcellos et al. (2023), which analyzed data up to 2020, observed a decrease in hospitalizations for PD in the SUS during the pandemic period, possibly reflecting restricted access to non-urgent health services or fear of contamination, which introduces significant variability into the historical series [31]. The lack of statistical significance in the overall trend (GLS β₁=0.031, p = 0.682) and the considerable interannual variability suggest that the demographically driven increase in disease burden may be attenuated or obscured by fluctuations in access to care and the effectiveness of health policies. The divergence between the sexes, with a more pronounced increase in men, requires future investigations that consider specific environmental and biological risk factors, as well as the interaction with public health policies [25, 26]. The neurology workforce in Brazil displays a pattern of regional distribution inequality that poses a greater challenge than the absolute shortage of professionals. Although the number of neurologists per 100,000 inhabitants has increased over the past decade (2010–2020), this growth has not occurred uniformly across the country. There is a marked imbalance, with the North and Northeast regions showing the lowest per-capita rates of neurologists compared to the South and Southeast, where the concentration is substantially higher. This disparity in distribution is strongly correlated with social inequality and directly affects the population’s access to specialized neurological care, which is essential for the diagnosis and treatment of chronic conditions such as PD [32]. In this scenario, Brazil’s Unified Health System (SUS) hospitalization data acquire systemic relevance, acting as a proxy for the severity and complexity of care. Hospitalization for PD, often associated with advanced motor complications, falls, infections, or adverse drug effects, signals failures in outpatient management and primary care [33]. The review by Bovolenta et al. (2017) highlights the need for policies that accompany the demographic transition, ensuring that the legal framework and clinical guidelines translate into a real increase in specialized care capacity in all regions, mitigating the observed disparities and ensuring the survival and quality of life of PD patients in Brazil [34]. Also, our findings call for tailored strategies addressing sex-specific needs in PD management to reduce preventable hospitalizations, which often result from complications such as falls, infections, or medication side effects, signaling a failure in optimal outpatient care [35]. Resource planning must account for these sex-specific patterns; for instance, rehabilitation programs and specialized reference centers should be strategically developed and geographically distributed to mitigate the regional inequalities inherent to the SUS [36]. By strengthening primary and secondary care focusing on early identification of high-risk patients, optimizing polypharmacy management, and ensuring access to multidisciplinary teams (including physical and speech therapists) across all regions allows a substantial reduction of the burden on tertiary hospital care. The data presented here, therefore, serves as a crucial metric for policymakers, highlighting areas where investment in specialized outpatient infrastructure is most needed to improve the quality of life for PD patients and ensure the sustainability of the public health system [37–39]. Taken together, these findings position hospitalization rates not only as epidemiological indicators but as strategic metrics for guiding healthcare planning. They identify priority areas for investment in specialized outpatient infrastructure, gender-sensitive models of care, and regional equity, all of which are essential to improving quality of life for patients with PD and ensuring the sustainability of the Brazilian healthcare system. Limitations This study has various inherent limitations to the use of secondary administrative data which we addressed through specific methodological choices to preserve the robustness of our findings. First, due to its ecological design, the analysis is based on aggregated population-level data and does not allow for individual-level inference, but it is appropriate for characterizing population-wide trends and burden.To prevent confounding by the aging of the Brazilian population, rates were directly age-standardized to the WHO World Standard Population. Second, the relatively small number of time points (n = 15) may limit the statistical power to detect subtle temporal trends and increases susceptibility to random year-to-year variability. We therefore adopted an analytical framework suited to this structure: Poisson regression with a log-population offset and a Generalized Least Squares model with an explicit AR(1) error structure (Prais–Winsten), motivated by the strong serial autocorrelation detected in the raw series (Durbin–Watson = 0.066). Newey–West HAC standard errors were used as a secondary check, and the convergence of estimates across models supports the consistency of the observed trend. Third, the SIH/SUS records hospital admissions across a healthcare system marked by substantial regional heterogeneity in access to specialists, diagnostic infrastructure, and coverage. As a result, admission diagnoses are not always established by neurologists and may be recorded by non-specialists, which can lead to misclassification, underreporting, and inconsistent coding of Parkinson’s disease across regions and institutions. To minimize this, case ascertainment was restricted to ICD-10 G20 in the primary diagnosis field (the most specific coding available in the system). Finally, because the SIH/SUS registers admission events rather than unique patients, repeated admissions are counted separately. This precludes incidence estimation but is appropriate for quantifying the hospitalization burden of Parkinson’s disease, which is the outcome of interest here. Overall, the combination of age standardization, autocorrelation-adjusted modeling, and restrictive case definition supports the validity of the temporal trends and sex differences reported. Conclusion In conclusion, this long-term nationwide time-series analysis provides the first comprehensive assessment of sex-related differences in Parkinson’s disease hospitalization rates across Brazil, revealing a significantly higher hospitalization burden among males throughout the 2010–2024 period. Although the overall temporal trend was not statistically significant after adjustment for autocorrelation, males consistently exhibited higher hospitalization rates than females across the study period. The observed patterns may partially reflect the effects of population aging as well as differences in disease burden and healthcare utilization between sexes. These findings highlight the importance of considering sex-specific patterns in Parkinson’s disease when planning healthcare services and developing strategies aimed at reducing preventable hospitalizations. To advance the understanding of PD burden, future research should integrate these hospitalization findings with other critical metrics, including outpatient service utilization, detailed mortality records, and the overall economic burden of the disease on the SUS. Specifically, further analyses should focus on regional stratification and predictive modeling of trends to better anticipate resource demands. Moreover, to elucidate the biological and social underpinnings of the observed sex disparity, future studies must investigate sex-specific progression patterns and the role of biomarkers, such as α-synuclein, estrogen levels, and chronic inflammation, which may drive differential disease severity and complication rates between men and women. Overall, the results underscore the relevance of considering sex- and age-specific patterns in Parkinson’s disease hospitalization as part of healthcare planning and resource allocation, particularly in the context of aging populations. Supplementary Information Supplementary Material 1. Supplementary Material 1. Supplementary Material 2. Supplementary Material 2. Supplementary Material 3. Supplementary Material 3.